EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review

Lingling Hu, Lulu Luo, Nan Yao, Jie Mi, Yuexian Zhang, Ming Sun, Huaping Wang, Yanling Xu, Wei Wang, Jiong Hu, Hongbin Lu

Frontiers in Oncology · 20.03.2026 · 16

DOI: 10.3389/fonc.2026.1744590 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.03.2026. Verfasst von Lingling Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Wuxi Branch of Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Wuxi, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunoglobulin light-chain (AL) amyloidosis is a rare systemic disease caused by the extracellular deposition of misfolded light chains. Nonspecific manifestations, especially those dominated by severe autonomic neuropathy, frequently delay diagnosis. Methods and results A 68-year-old woman was admitted after five months of recurrent syncope. The clinical picture was dominated by refractory orthostatic hypotension, nausea and vomiting alternating with diarrhea and constipation, stocking-glove paresthesias, and proteinuria. Bone marrow examination showed the presence of clonal plasma cells with positive M protein, which was confirmed by the serum free light chain test. AL amyloidosis was diagnosed based on positive Congo red staining in renal biopsy specimens. The patient was enrolled in a daratumumab-based protocol combined with daratumumab, bortezomib, cyclophosphamide, and dexamethasone. After three cycles, complete hematological remission was achieved, and the autonomic nerve function improved gradually over the subsequent six months.

Conclusion

This case and literature review suggest that AL amyloidosis should be considered whenever a patient presents with multisystem dysfunction dominated by autonomic nerve dysfunction. Although such presentations are associated with poor prognosis, prompt initiation of daratumumab-based therapy can produce rapid hematologic remission and clinically meaningful improvement.

Schlagwörter

Stichwörter der Autor:innen

autonomic nervous systemdaratumumabhypotensionlight chain amyloidosissyncope

Autor:innen und Institutionen

  • Department of Hematology, Wuxi Branch of Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Wuxi, China.
  • Department of Radiation Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
  • Shanghai Institute of Hematology, Blood and Marrow Transplantation Center, Collaborative Innovation Center of Hematology, Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shan…

Zitieren

APA

Hu, L., Luo, L., Yao, N., Mi, J., Zhang, Y., Sun, M., Wang, H., Xu, Y., Wang, W., Hu, J., & Lu, H. (2026). Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1744590

Vancouver

Hu L, Luo L, Yao N, Mi J, Zhang Y, Sun M, et al. Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1744590

BibTeX
@article{Hu2026,
  author = {Hu, Lingling and Luo, Lulu and Yao, Nan and Mi, Jie and Zhang, Yuexian and Sun, Ming and Wang, Huaping and Xu, Yanling and Wang, Wei and Hu, Jiong and Lu, Hongbin},
  title = {Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1744590}
}
Kostenlos starten →